SEATTLE AP – Seattle biotechnology firm Cell Therapeutics Inc. can pursue claims for nearly $23 million against a former consultant, a federal appeals court ruled Wednesday.

The ruling by a three-judge panel of the 9th U.S. Circuit Court of Appeals overturned the ruling of a judge in Seattle and created a new interpretation of law surrounding fraud cases brought on behalf of the government.